Here are relevant reports on : animal-diagnostics-market
-
Animal Parasiticides Market by Type (Ectoparasiticide, Endoparasiticide, Endectocide, Spray, Feed Additives), Animal Type (Dog, Cat, Horse, Cattle, Pig, Poultry), End user (Hospital, Animal farm, Home Care Setting) & Region - Global Forecast to 2031
The global animal parasiticides market is projected to reach USD 17.50 billion by 2031, growing at a CAGR of 6.2% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
Precision Diagnostics & Medicine Market by Diagnostic Testing (Genetic, DTC), Diagnostics Indication (Oncology, Neurology, Immunology), Therapeutic Products (Inhibitors, mAbs, CGT), Indication (Oncology, Rare Disease, Infectious) - Global Forecast to 2029
The global precision diagnostics and medicine market, valued at US$132.46 billion in 2023, stood at US$145.53 billion in 2024 and is projected to advance at a resilient CAGR of 11.1% from 2024 to 2029, culminating in a forecasted valuation of US$246.66 billion by the end of the period. Factors such as the growing integration of AI and ML to enhance precision diagnostics and medicine development supported by rising collaborations between pharmaceutical and diagnostics companies to improve precision healthcare and the rise in direct-to-consumer testing are driving the growth in the market.
- Published: January 2025
- Price: $ 4950
- TOC Available:
-
Exosome Diagnostics and Therapeutics Market by Type (Diagnostics, Therapeutics), Product & Service (Instruments, Kits, Reagents), Source (Stem Cells, Blood, Blood Plasma, Urine), Application (Cancer, Musculoskeletal, CVD) - Global Forecast to 2032
The global exosome diagnostics and therapeutics market, valued at US$33 million in 2023, stood at US$59 million in 2024 and is projected to advance at a resilient CAGR of 81.2% from 2024 to 2032, culminating in a forecasted valuation of US$6,848 million by the end of the period. The growth of this market is driven by factors such as the increasing collaborations & commercialization initiatives, emerging potential of exosome-based liquid biopsy, and growing outsourcing of exosome manufacturing activities.
- Published: June 2024
- Price: $ 4950
- TOC Available:
-
Malaria Diagnostics Market by Technology (Microscopy, Rapid Diagnostic Tests, Molecular Diagnostic Tests), End User (Hospitals, Clinics, Diagnostics Centers, and Others), and Geography - Global Forecast to 2027
The global malaria diagnostics market size is projected to reach USD 1.02 Billion by 2027 from USD 770.5 million in 2022, at a CAGR of 5.4% during the forecast period. Market is driven by factors such as rise in the prevalence of malaria in developing countries. Moreover, the surge in awareness initiatives by governments and the increase in research for new malaria diagnostics are the factors that boost the growth of this market. However, lack of alertness about healthcare in developing countries is a major factor that restricts the malaria diagnostics market growth.
- Published: December 2026
- Price: $ 4950
- TOC Available:
-
Preventive Diagnostics Market for Substation Equipment by Diagnostics Type (Partial Discharge, Dissolved Gas Analysis & Oil-Gas, Thermal/Infrared, Insulating Gas Condition, Bushing, Mechanical, Vibration, & Acoustic Condition) - Forecast to 2036
The preventive diagnostic market for substation equipment is projected to reach USD 3.46 billion by 2036 from USD 1.91 billion in 2026, at a CAGR of 6.1%. The preventive diagnostic market for substation equipment includes many major players, including Siemens Energy (Germany), GE Vernova (US), ABB (Switzerland), Hitachi Energy Ltd (Switzerland), Schneider Electric (France), Qualitrol Company LLC (US), Doble Engineering Company (US), OMICRON (Austria), Rugged Monitoring (Canada), and Dynamic Ratings (US).
- Published: October 2026
- Price: $ 4950
- TOC Available:
-
Noninvasive Cancer Diagnostics Market by Instruments (Solid Tumor, Blood Cancer, Lung Cancer, Breast Cancer), Technology (Clinical Chemistry, Immunochemistry, Molecular Diagnostics) - Analysis & Global Forecast to 2019
The global non-invasive cancer diagnostic market is expected to show considerable growth during the forecast period. This is attributed to growing cancer cases worldwide, especially breast and lung cancer. In 2013, in the U.S. there were more than 1,660,290 new cases of all type of cancers diagnosed in 2013 (American Cancer Society). Increased healthcare expenditure and increase research and development activities are some of the other factors driving the growth of this market. However factors such as high cost of treatment, and stringent regulatory guidelines are limiting the market growth.
- Published: December 2026
- Price: $ 4950
- TOC Available:
-
Asia Pacific Animal Health Market by product (Parasiticides (Ectoparasiticides), Antimicrobial & Antibiotic, Vaccines, Feed Additive( Vitamin, Amino Acids, Antioxidant), Growth Promoter) Animal (Livestock, Companion), End-user (Hospitals) & Region - Global Forecast to 2025
The global Asia Pacific Animal Health Market in terms of revenue was estimated to be worth $15.6 billion in 2020 and is poised to reach $22.1 billion by 2025, growing at a CAGR of 7.2% from 2020 to 2025. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.
- Published: November 2020
- Price: $ 4950
- TOC Available:
-
Viscosupplementation Market by Product (Single, Three, Five Injection), Application (knee, hip osteoarthritis), Source (animal, non-animal), End-user (Hospitals, Orthopedic Clinics/ASCs), Region (northamerica, Asia Pacific, Europe) - Forecast to 2027
The global Viscosupplementation market size is projected to reach USD XX million by 2027 from USD XX million in 2022, at a CAGR of XX% during the forecast period. The market is driven by factors such as the increasing global prevalence of osteoarthritis, the increasing geriatric population, and the rise in sports injuries. On the other hand, the high cost of products is expected to limit market growth to a certain extent in the coming years.
- Published: December 2026
- Price: $ 4950
- TOC Available:
-
Veterinary CT Scanner Market by Type (Multi Slice CT Scanner, Portable CT Scanner), Animal (Small Animals, Equine, Livestock), Application (Neurology, Oncology, Orthopedic, Traumatology), End User (Animal Hospital, Clinic) - Global Forecast to 2022
The veterinary CT scanner market is expected to reach USD 173.7 Million by 2022 from an estimated USD 122.3 Million in 2017, at a CAGR of 7.3%. The key players in the global veterinary CT scanner market are GE Healthcare (US), Canon, Inc. (Toshiba Medical Systems Corporation) (Japan), Siemens AG (Siemens Healthineers) (Germany), Samsung Electronics Co. Ltd. (NeuroLogica Corporation) (South Korea), Epica Medical Innovation (US), Hitachi, Ltd. (Japan), Koninklijke Philips N.V. (Netherlands), Animage, LLC (US), GIN ApS (Denmark), QR s.r.l. (Italy), and 4DDI (US).
- Published: August 2017
- Price: $ 4950
- TOC Available:
-
Asia Pacific Animal Parasiticides Market by Type [Ectoparasiticides (Pour-ons & Spot-ons, Dips), Endoparasiticides (Oral Liquids, Injectables, Feed Additives), Endectocides], Animal Type (Companion Animals, Livestock), End User - Forecast to 2031
The Asia Pacific animal parasiticides market, valued at USD 2.12 billion in 2025, stood at USD 2.26 billion in 2026 and is projected to advance at a resilient CAGR of 7.2% from 2026 to 2031, culminating in a forecasted valuation of USD 3.20 billion by the end of the period. The Asia Pacific animal parasiticides market is growing due to rising levels of parasite infestation among livestock and companion animals, expanding animal populations, and greater focus on preventive animal healthcare.
- Published: November 2026
- Price: $ 4950
- TOC Available:
Records 11 to 20 of 50
